Minakem is manufacturing small molecules APIs including corticosteroids
01 1DELMAR CHEMICALS INC
02 1Calyx Chemicals & Pharmaceuticals Limited
03 1DARMERICA, LLC
01 1PYRAZINAMIDE
02 2Pyrazinamide
01 1Canada
02 1India
03 1U.S.A
Minakem is manufacturing small molecules APIs including corticosteroids
NDC Package Code : 11712-815
Start Marketing Date : 1999-05-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66639-165
Start Marketing Date : 2009-09-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-027
Start Marketing Date : 2024-03-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Pyrazinamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pyrazinamide, including repackagers and relabelers. The FDA regulates Pyrazinamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pyrazinamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pyrazinamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pyrazinamide supplier is an individual or a company that provides Pyrazinamide active pharmaceutical ingredient (API) or Pyrazinamide finished formulations upon request. The Pyrazinamide suppliers may include Pyrazinamide API manufacturers, exporters, distributors and traders.
click here to find a list of Pyrazinamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pyrazinamide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pyrazinamide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pyrazinamide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pyrazinamide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pyrazinamide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pyrazinamide suppliers with NDC on PharmaCompass.
We have 3 companies offering Pyrazinamide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
